DISHMAN

HDFC Standard Life Insurance Co. Ltd has submitted to the Exchange vide letter dated June 12, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain close from August 23, 2014 to September 4, 2014 (both days inclusive) for the purpose of determining the entitlement of final dividend and for AGM to be held on September 04, 2014.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Board of Directors at their meeting held on May 28, 2014, for the financial year 2013-2014, the Board has recommended the final dividend @ 60% (i.e. Rs.1.20 per equity share of Rs.2.00 each) on the paid-up equity share capital of the Company.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2014.

Janmejay R Vyas has submitted to the Exchange vide letter dated April 23, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Kotak Mahindra Investments Limited has submitted to the Exchange vide letter dated April 2, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated April 03, 2014 a copy of Disclosure in terms of Regulation 13(2) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated April 03, 2014 a copy of Disclosure in terms of Regulation 13(4) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Janmejay R. Vyas has submitted to the Exchange vide letter dated April 2, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Mr. Rajashekhar Bhat has been appointed as a Global Chief Financial Officer ("CFO") of the Dishman Group of Companies w.e.f. April 01, 2014.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated March 28, 2014 a copy of Disclosure in terms of Regulation 13(2), 13(2A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Mr. Tushar Shah has been appointed as a "Company Secretary and Compliance officer" of the Company w.e.f March 27, 2014.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated March 20, 2014 a copy of Disclosure in terms of Regulation 13(2) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

The Exchange had sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to a news item captioned "Dishman plans to sell Gujarat land to Nirma, exit SEZ biz". The Company has clarified that "This is a market rumor and there is no truth in the said news. None of the Company's officials have given this information to media. In fact the said SEZ land is owned by the Group company Dishman Infrastructure Ltd. and has nothing to do with Dishman Pharmaceuticals and Chemicals Limited. The Company also does not envisage Sale of the China facility".

Dishman Pharmaceuticals and Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Dec-2013.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Employees of the Company shall remain close from February 01, 2014 to February 15, 2014 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated January 27, 2014 a copy of Disclosure in terms of Regulation 13(2) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Mr. Deepak S. Pandya Vice President (Legal) & Company Secretary has resigned from the services of the Company. The Company accepted his resignation and relieved him of his responsibilities effective close of business hours on December 29, 2013. Consequent to his resignation as Company Secretary, Mr. Pandya also ceases to be Compliance Officer of the Company.

Spurt in Volume : Substantial increase in trading volumes have been observed in Dishman Pharmaceuticals and Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dishman Pharmaceuticals and Chemicals Limited has vide its letter inter-alia stated, "We would like to state that to the best of our knowledge and belief, there is no price sensitive information / development which can have a bearing on the performances of the

Dishman Pharmaceuticals and Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-sep-2013.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange vide letter dated October 12, 2013, "Intimation regarding survey conducted by Income Tax Department".

Arpit J Vyas has submitted to the Exchange vide letter dated September 17, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated September 16, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated September 05, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated September 04, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated September 03, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated September 03, 2013 a copy of Disclosure in terms of Regulation 13(4) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arpit J Vyas has submitted to the Exchange vide letter dated September 02, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J. Vyas has submitted to the Exchange, vide letter dated August 30, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated August 29, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated August 29, 2013 a copy of Disclosure in terms of Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arpit J Vyas has submitted to the Exchange vide letter dated August 28, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 27, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 26, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 23, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 19, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 23, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 21, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, vide letter dated August 21, 2013 a copy of Disclosure in terms of Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arpit J Vyas has submitted to the Exchange vide letter dated August 16, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 14, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 21, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange, vide letter dated August 19, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated August 13, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Arpit J Vyas has submitted to the Exchange vide letter dated August 13, 2013, a copy of revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated August 14, 2013 a copy of Disclosure under Regulation 13(4) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arpit J Vyas has submitted to the Exchange vide letter dated August 08, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Arpit J Vyas has submitted to the Exchange vide letter dated August 07, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arpit J Vyas has submitted to the Exchange vide letter dated August 06, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated August 7, 2013 a copy of Disclosure under Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.